Ocumetics Technology Corp
XTSX:OTC
Ocumetics Technology Corp
XTSX:OTC
Price:
0.61
CAD
3.39%
Market Closed
Market Cap:
CA$30.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ocumetics Technology Corp
Other Liabilities
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Ocumetics Technology Corp
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ocumetics Technology Corp
XTSX:OTC
|
Other Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Z
|
Zentek Ltd
XTSX:ZEN
|
Other Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ostrom Climate Solutions Inc
XTSX:COO
|
Other Liabilities
CA$1.4m
|
CAGR 3-Years
170%
|
CAGR 5-Years
46%
|
CAGR 10-Years
9%
|
|
|
Bausch + Lomb Corp
NYSE:BLCO
|
Other Liabilities
$521m
|
CAGR 3-Years
17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Ocumetics Technology Corp
Glance View
Ocumetics Technology Corp. engages in the development of bio lens to completely eliminate the need for corrective lenses, especially for people over 45 years of age. The company is headquartered in Calgary, Alberta. The company went IPO on 2018-08-29. The firm specializes in medical optics and refractive technologies. The firm focuses on the development of an intra-ocular lens known as the Bionic Lens. The Bionic Lens is an intraocular lens that fits within the natural lens compartment of the eye to eliminate the need for corrective lenses.
OTC
Intrinsic Value
Not Available
